中文名 | 1-[(4-甲基苯基)磺酰基]-4-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)-1H-吡咯并[2,3-b]吡啶 |
---|---|
英文名 | 1-(4-methylphenyl)sulfonyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridine |
英文别名 |
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine
1-[(4-methylphenyl)sulphonyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(toluene-4-suIfonyl)-1H-pyrrolo[2,3-b]pyridine 1-Tosyl-1H-Pyrrolo[2,3-B]pyridine-4-boronic acid pinacol ester 1-[(4-Methylphenyl)sulfonyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine |
分子式 | C20H23BN2O4S |
---|---|
分子量 | 398.28400 |
精确质量 | 398.14700 |
PSA | 78.80000 |
LogP | 3.96170 |
~97% 916176-50-6 |
文献:VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2006/127587 A1, 2006 ; Location in patent: Page/Page column 86 ; WO 2006/127587 A1 |
~% 916176-50-6 |
文献:US2011/306613 A1, ; |
~% 916176-50-6 |
文献:US2011/306613 A1, ; |
~% 916176-50-6 |
文献:US2011/306613 A1, ; |
上游产品 5 | |
---|---|
下游产品 0 |